The patient monitoring market includes diagnostic and measurement devices, exhalation monitors, multiparameter patient monitoring, neonatal monitors, operating room Integration systems, and remote patient monitoring. Sleep apnea diagnostic systems include polysomnography systems (PSG systems) used for the screening of sleep apnea. GlobalData uses proprietary data and analytics to provide a comprehensive report on the sleep apnea diagnostic systems devices market, including market shares of different players within Australia. Buy the latest report here.

Smarter leaders trust GlobalData

In 2022, GlobalData’s Market Model methodology determined that the leading player in the sleep apnea diagnostic systems market in Australia was Compumedics followed by Nihon Kohden, Natus Medical, Koninklijke Philips, Becton Dickinson and Co, ResMed, Somnomedics, Heinen + Lowenstein and Drive Medical.

Sleep Apnea Diagnostic Systems includes systems and devices used for the diagnosis of sleep apnea. One PSG system includes amplifiers, hard disk, monitor, recorder, laser printer, electrodes, cables, stands, stimulators, chest and abdomen respiration belt and sensors. Fixed and portable polysomnography systems are tracked under this category. Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. Obstructive Sleep Apnea (OSA) is the common type of sleep apnea, it causes snoring when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Polysomnogram is the most common sleep study for diagnosing OSA. This study records brain activity, eye movements, heart rate and blood pressure.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the sleep apnea diagnostic systems devices market within Australia was expected to be over $60m in 2022.

For the latest complete market share analysis of sleep apnea diagnostic systems device market in Australia, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.